Similar articles

• 5-HT3 receptor antagonist for the treatment of tendinopathy.

  Mousavizadeh K, Stratz T, Mueller W, Fiebich BL. Mousavizadeh K, et al. Nat Clin Pract Rheumatol. 2008 Jul;4(7):E4. Nat Clin Pract Rheumatol. 2008. PMID: 18597984 No abstract available.
• 5-HT3 receptors antagonists reduce serotonin-induced scratching in mice.

  Ostadhadi S, Kordjazy N, Haj-Mirzaian A, Mansouri P, Dehpour AR. Ostadhadi S, et al. Fundam Clin Pharmacol. 2015 Jun;29(3):310-5. doi: 10.1111/fcp.12112. Epub 2015 Mar 31. Fundam Clin Pharmacol. 2015. PMID: 25711853
• Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.

  Dhar AK, Mahesh R, Jindal A, Bhatt S. Dhar AK, et al. Arch Pharm (Weinheim). 2015 Jan;348(1):34-45. doi: 10.1002/ardp.201400293. Arch Pharm (Weinheim). 2015. PMID: 25581677
• Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT₃ Receptor Antagonists for Postoperative Nausea and Vomiting.

  Kovac AL. Kovac AL. Drugs. 2016 Dec;76(18):1719-1735. doi: 10.1007/s40265-016-0663-3. Drugs. 2016. PMID: 27988869 Review.
• From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists.

  Fakhfouri G, Mousavizadeh K, Mehr SE, Dehpour AR, Zirak MR, Ghia JE, Rahimian R. Fakhfouri G, et al. Mol Neurobiol. 2015 Dec;52(3):1670-1679. doi: 10.1007/s12035-014-8957-5. Epub 2014 Nov 7. Mol Neurobiol. 2015. PMID: 25377794 Review.